🧪 Standard Operating Procedure (SOP) for Out of Specification (OOS) Investigation

1. Introduction

An Out of Specification (OOS) result is a test result that falls outside approved acceptance criteria. Proper investigation of OOS results is essential to ensure data integrity, product quality, and regulatory compliance.

2. Purpose

To define a scientifically sound and compliant procedure for identification, investigation, documentation, and closure of OOS results in accordance with FDA, MHRA, EMA, WHO, ICH, and PIC/S guidelines.

3. Scope

Applicable to all OOS results generated during raw material, in-process, finished product, stability, validation, and method transfer testing.

4. Responsibilities

Analyst: Report OOS immediately and secure all data.
QC Supervisor: Initiate and review Phase I investigation.
Quality Assurance: Oversee investigation and approve conclusions.
Manufacturing: Support Phase II investigation when required.
Lab Manager: Ensure timely investigation and closure.

5. Definitions

OOS: Out of Specification result.
OOT: Out of Trend result.
Phase I: Laboratory investigation.
Phase II: Manufacturing/process investigation.
Assignable Cause: Identifiable reason for failure.
CAPA: Corrective and Preventive Action.

6. OOS Investigation Procedure

6.1 Identification and Initial Action

Notify QC Supervisor and QA immediately.
Quarantine samples, standards, and reagents.
Secure raw data, worksheets, and audit trails.
Log the OOS in the OOS register.

6.2 Phase I – Laboratory Investigation

Verify calculations, integrations, and specifications.
Review analyst technique and method adherence.
Check instrument calibration and system suitability.
Review reagents, standards, and sample preparation.

6.3 Phase II – Manufacturing Investigation

Initiated if no laboratory assignable cause is found.
Review batch records, deviations, IPC data.
Assess raw materials, equipment, and process conditions.

7. Detailed OOS Investigation Procedure – Phase I & Phase II

7.1 Phase I – Laboratory Investigation (Step-by-Step)

Phase I investigation focuses on identifying any potential laboratory-related error. This phase must be completed before initiating any manufacturing or process investigation.

Step 1: Immediate Result Assessment

Confirm that the result is truly OOS against the approved specification.
Verify correct test method, version, and specification limits were used.
Ensure no transcription or reporting errors occurred.

Step 2: Data Integrity and Calculation Review

Review raw data, worksheets, and electronic records.
Recheck all calculations, dilutions, and formulae.
Verify chromatographic integrations and peak assignments.
Review audit trails for any data reprocessing or changes.

Step 3: Analyst Performance Review

Confirm analyst training, qualification, and authorization.
Interview the analyst to understand test execution.
Check adherence to the approved analytical method.
Review any deviations or unusual observations during testing.

Step 4: Instrument and Equipment Evaluation

Verify instrument calibration, qualification, and maintenance status.
Review system suitability results.
Check instrument logs for errors, alarms, or abnormal performance.
Assess software configuration and processing parameters.

Step 5: Reagents, Standards, and Glassware Review

Confirm identity, expiry, preparation, and storage of reagents and standards.
Review reference standard certificates and potency calculations.
Check glassware cleanliness and suitability.
Verify correct labeling and traceability.

Step 6: Sample Handling and Preparation Review

Verify sample identity and chain of custody.
Assess storage conditions and holding times.
Review sample preparation steps for errors or deviations.
Check for potential contamination or degradation.

Step 7: Environmental and Laboratory Conditions

Review laboratory temperature and humidity records.
Assess impact of power failures, vibrations, or interruptions.
Evaluate any relevant laboratory deviations.

Step 8: Phase I Conclusion

Determine whether a clear laboratory assignable cause exists.
If assignable cause is identified, document evidence and rationale.
If no assignable cause is found, escalate to Phase II.
Obtain QA review and approval of Phase I conclusion.

7.2 Phase II – Manufacturing / Process Investigation (Step-by-Step)

Phase II investigation is initiated when Phase I does not identify a laboratory-related assignable cause. This phase evaluates the impact on the batch and the manufacturing process.

Step 1: Batch Impact Assessment

Identify all batches potentially impacted.
Assess distribution status and quarantine affected batches.
Inform QA and relevant stakeholders.

Step 2: Batch Manufacturing Record Review

Review executed batch records for completeness and accuracy.
Evaluate critical process parameters and in-process controls.
Review deviations, change controls, and non-conformances.

Step 3: Raw Material and Component Evaluation

Review raw material COAs and release status.
Assess supplier quality and recent supplier changes.
Check storage, handling, and dispensing records.

Step 4: Equipment and Facility Review

Review equipment cleaning, calibration, and maintenance records.
Check for equipment malfunctions or alarms.
Evaluate facility conditions and utilities (HVAC, water, gases).

Step 5: Process and Environmental Factors

Assess environmental monitoring data.
Review operator practices and shift changes.
Evaluate potential mix-ups or cross-contamination risks.

Step 6: Trend and Historical Data Review

Review historical OOS, OOT, and deviation trends.
Assess whether similar failures occurred previously.
Identify systemic or recurring issues.

Step 7: Root Cause Confirmation

Apply formal root cause analysis tools (5-Why, Fishbone).
Confirm root cause with objective evidence.
Document justification clearly.

Step 8: CAPA and Final Conclusion

Define corrective and preventive actions.
Assign responsibilities and timelines.
Assess product quality and patient impact.
Obtain QA approval for final OOS conclusion and batch disposition.

Phase II investigation outcomes shall determine batch disposition, regulatory reporting requirements, and long-term process improvements.

8. Root Cause Identification & Reanalysis

8.1 Root Cause Identification

Review raw data, calculations, and audit trails.
Assess analyst training and method execution.
Verify instrument performance and maintenance.
Check reagents, standards, sample integrity, and storage.
Review environmental and laboratory conditions.
Apply 5-Why or Fishbone analysis.

Root cause conclusions must be supported by objective evidence and approved by QA.

8.2 Reanalysis / Retesting Procedure

Permitted only when a clear laboratory assignable cause is identified.
QA approval is mandatory prior to reanalysis.
Reanalyze original sample using the same validated method.
Preferably perform by a different qualified analyst.
All results (passing and failing) must be reported.
Testing into compliance is strictly prohibited.

9. Regulatory Expectations

9.1 FDA

FDA Guidance for Industry: Investigating OOS Test Results.
Mandatory Phase I and Phase II investigations.
No invalidation without scientific justification.

9.2 MHRA

Strong focus on data integrity and ALCOA+.
QA oversight and trend analysis required.

9.3 Other Guidelines

ICH Q7, Q9, Q10
WHO TRS
PIC/S GMP
EU GMP Chapters 1 & 6

10. Documentation & Records

OOS notification form
Investigation worksheets
Raw data and audit trails
CAPA records
Final OOS report